| Analytical Validation of Circulating DNA Analysis Methods: Creation of a Control Cohort (NCT07663994) | Institut Claudius Regaud | 2026-07-16 |
| Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2 (NCT07558343) | Institut Claudius Regaud | 2026-06-15 |
| Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer (NCT07427186) | Institut Claudius Regaud | 2026-04-15 |
| Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers (NCT07233928) | Institut Claudius Regaud | 2026-02-06 |
| Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome (NCT06917781) | Institut Claudius Regaud | 2025-10-28 |
| Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention (NCT06599879) | Institut Claudius Regaud | 2025-10-21 |
| Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI. (NCT07195344) | Institut Claudius Regaud | 2025-10-15 |
| Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer (NCT06904625) | Institut Claudius Regaud | 2025-08-14 |
| Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers (NCT06967961) | Institut Claudius Regaud | 2025-07-23 |
| Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM) (NCT06797037) | Institut Claudius Regaud | 2025-05-19 |
| Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour (NCT06876532) | Institut Claudius Regaud | 2025-04-07 |
| Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy (NCT06588322) | Institut Claudius Regaud | 2025-01-08 |
| Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study (NCT06589414) | Institut Claudius Regaud | 2025-01-08 |
| Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas (NCT06557889) | Institut Claudius Regaud | 2024-10-21 |
| Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma (NCT06222138) | Institut Claudius Regaud | 2024-08-27 |
| Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their Partners (NCT06517355) | Institut Claudius Regaud | 2024-07-30 |
| Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer (NCT06408038) | Institut Claudius Regaud | 2024-06-25 |
| Optimization With a Gamma Camera of the Individualized Patient Dosimetry in Radioiodine Therapy of Thyroid Diseases (NCT06371339) | Institut Claudius Regaud | 2024-04-25 |
| Male breAsT cAncer preDisposition Factor (NCT06219187) | Institut Claudius Regaud | 2024-02-08 |
| Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients (NCT05988970) | Institut Claudius Regaud | 2024-01-29 |
| PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer (NCT05581121) | Institut Claudius Regaud | 2023-12-20 |
| Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma (NCT05821231) | Institut Claudius Regaud | 2023-12-12 |
| A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa. (NCT06022159) | Institut Claudius Regaud | 2023-11-28 |
| Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene. (NCT06022016) | Institut Claudius Regaud | 2023-11-17 |
| Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae (NCT05757817) | Institut Claudius Regaud | 2023-11-08 |
| SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer (NCT05826509) | Institut Claudius Regaud | 2023-08-10 |
| A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors. (NCT03966651) | Institut Claudius Regaud | 2023-04-17 |
| Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2 (NCT05427461) | Institut Claudius Regaud | 2023-01-13 |
| Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma (NCT05867004) | Institut Claudius Regaud | 2023-01-01 |
| Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of Innovations (NCT05865964) | Institut Claudius Regaud | 2022-12-14 |
| Accompaniment of Patients by Dental Assistants in the Evaluation of Oral Hygiene During and After Radiotherapy Treatment. (NCT05494970) | Institut Claudius Regaud | 2022-10-13 |
| Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma (NCT04515459) | Institut Claudius Regaud | 2022-09-13 |
| Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. (NCT05378204) | Institut Claudius Regaud | 2022-06-23 |
| Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents (NCT05151718) | Institut Claudius Regaud | 2021-09-30 |
| Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE) (NCT04940000) | Institut Claudius Regaud | 2021-09-02 |
| A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation (NCT03955198) | Institut Claudius Regaud | 2021-05-27 |
| Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain. (NCT04704453) | Institut Claudius Regaud | 2021-04-28 |
| Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group (NCT03967834) | Institut Claudius Regaud | 2021-04-26 |
| Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance (NCT04821336) | Institut Claudius Regaud | 2021-04-15 |
| Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer. (NCT04818125) | Institut Claudius Regaud | 2021-03-31 |
| Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer (NCT04740697) | Institut Claudius Regaud | 2021-02-12 |
| Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma (NCT04696692) | Institut Claudius Regaud | 2021-02-09 |
| Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy (NCT04513444) | Institut Claudius Regaud | 2020-12-07 |
| Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma? (NCT04512495) | Institut Claudius Regaud | 2020-10-22 |
| Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma (NCT04307277) | Institut Claudius Regaud | 2020-10-09 |
| The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane. (NCT03619044) | Institut Claudius Regaud | 2020-08-28 |
| Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy (NCT04428554) | Institut Claudius Regaud | 2020-06-30 |
| Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC (NCT04368468) | Institut Claudius Regaud | 2020-06-15 |
| Platino-resistance in Ovarian Cancer (NCT03954171) | Institut Claudius Regaud | 2020-03-06 |
| E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer. (NCT04228432) | Institut Claudius Regaud | 2020-02-28 |
| Deciphering Mechanisms Underlying Cancer Immunogenicity (NCT03958240) | Institut Claudius Regaud | 2020-01-17 |
| A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection. (NCT03986437) | Institut Claudius Regaud | 2020-01-13 |
| Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy (NCT03956498) | Institut Claudius Regaud | 2019-10-09 |
| Evaluation of the Adhesion to the GENEPY Network (NCT03979612) | Institut Claudius Regaud | 2019-08-01 |
| Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy (NCT03953352) | Institut Claudius Regaud | 2019-08-01 |
| Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer (NCT03956459) | Institut Claudius Regaud | 2019-07-25 |
| Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients (NCT03627026) | Institut Claudius Regaud | 2019-06-11 |
| Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy. (NCT03627988) | Institut Claudius Regaud | 2019-06-07 |
| Chronic Pain and Minor Breast Cancer Surgery (NCT03912948) | Institut Claudius Regaud | 2019-04-01 |
| Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial. (NCT03623646) | Institut Claudius Regaud | 2019-03-15 |
| Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA) (NCT03354962) | Institut Claudius Regaud | 2018-10-15 |
| FALCOn (Facteur AnthropoLogique Cancer Orl) (NCT03663985) | Institut Claudius Regaud | 2018-09-15 |
| TNF in Melanoma Patients Treated With Immunotherapy (NCT03348891) | Institut Claudius Regaud | 2018-09-05 |
| Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy (NCT03514368) | Institut Claudius Regaud | 2018-05-28 |
| Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma (NCT03514381) | Institut Claudius Regaud | 2018-05-18 |
| Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE). (NCT03447483) | Institut Claudius Regaud | 2018-04-20 |
| Optimization of the Patient Care Pathway in Immuno-oncology (NCT03329755) | Institut Claudius Regaud | 2017-12-26 |
| Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast Cancer (NCT03289286) | Institut Claudius Regaud | 2017-11-17 |
| TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma (NCT03293784) | Institut Claudius Regaud | 2017-10-16 |
| Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA) (NCT02866916) | Institut Claudius Regaud | 2017-09-01 |